×
About 2,675 results

ALLMedicine™ Cardiovascular Risk Management Center

Research & Reviews  281 results

Can cardiovascular risk management be improved by shared care with general practice to ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499986
BMC Geriatrics; Davison WJ, Myint PK et. al.

Sep 18th, 2020 - Cognitive impairment and dementia following cerebrovascular disease are increasingly common in the UK. One potential strategy to prevent post-stroke cognitive decline is multimodal vascular risk factor management. However, its efficacy remains unc...

Effectiveness of a prevention program in the incidence of cardiovascular outcomes in a ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500541
BMC Public Health; Miranda-Machado P, Salcedo-Mejía F et. al.

Sep 18th, 2020 - Cardiovascular diseases (CVDs) and diabetes mellitus (DM) are among the leading cause of morbidity and mortality in low-and-middle-income countries (LMICs) but evidence in these contexts regarding the effectiveness of primary prevention interventi...

Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women an...
https://doi.org/10.1097/SLA.0000000000004182
Annals of Surgery; Bulder RMA, Talvitie M et. al.

Jul 13th, 2020 - To evaluate the impact of changes in elective Abdominal Aortic Aneurysm (AAA) management on life-expectancy of AAA patients. Over the past decades AAA repair underwent substantial changes, that is, the introduction of EVAR and implementation of in...

Obesity and cardiovascular risk management is a critical way to reduce healthcare resou...
https://doi.org/10.1177/2047487320929248
European Journal of Preventive Cardiology; Chen L, Hao G

Jun 1st, 2020 - Obesity and cardiovascular risk management is a critical way to reduce healthcare resource pressure.|2020|Chen L,Hao G,|

Repurposing Available Anti-inflammatory and Immunomodulating Agents for Cardiovascular ...
https://doi.org/10.2174/157488471501200319150358
Current Clinical Pharmacology; Mangoni AA, Erre GL

May 14th, 2020 - Repurposing Available Anti-inflammatory and Immunomodulating Agents for Cardiovascular Risk Management: A Call for Submissions to Current Clinical Pharmacology.|2020|Mangoni AA,Erre GL,|

see more →

Guidelines  5 results

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduct...
http://www.onlinejacc.org/content/early/2018/11/23/j.jacc.2018.09.020

Nov 25th, 2018 - Despite major therapeutic advances leading to improved outcomes over the past 2 decades, cardiovascular (CV) disease remains the leading cause of morbidity and mortality in patients with type 2 diabetes (T2D) (1). Over that time, the prevalence of.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of ...
http://www.onlinejacc.org/content/early/2018/11/02/j.jacc.2018.11.003
Grundy, S.,et al

Nov 9th, 2018 - The recommendations listed in the present guideline are, whenever possible, evidence based. An initial extensive evidence review, which included literature derived from research involving human subjects, published in English, and indexed in MEDLIN.

Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018
http://care.diabetesjournals.org/lookup/doi/10.2337/dc18-S009
American Diabetes Association

Dec 31st, 2017 - Atherosclerotic cardiovascular disease (ASCVD)—defined as coronary heart disease, cerebrovascular disease, or peripheral arterial disease presumed to be of atherosclerotic origin—is the leading cause of morbidity and mortality for individuals with.

2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Sta...
http://www.onlinejacc.org/content/early/2017/08/30/j.jacc.2017.07.745
Lloyd-Jones, D.,et al.

Sep 4th, 2017 - In 2016, the American College of Cardiology published the first expert consensus decision pathway (ECDP) on the role of non-statin therapies for low-density lipoprotein (LDL)–cholesterol lowering in the management of atherosclerotic cardiovascular.

EULAR evidence-based recommendations for cardiovascular risk management in patients wit...
https://doi.org/10.1136/ard.2009.113696
Annals of the Rheumatic Diseases; Peters MJ, Symmons DP et. al.

Sep 23rd, 2009 - To develop evidence-based EULAR recommendations for cardiovascular (CV) risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). A multidisciplinary expert committee was convened as a t...

see more →

Drugs  1,027 results see all →

Clinicaltrials.gov  1,337 results

Lisinopril and hydrochlorothiazide - lisinopril and hydrochlorothiazide tablets tablet-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4c9abf7-a2c6-7042-e053-2a95a90a7653

Nov 22nd, 2020 - Lisinopril and hydrochlorothiazide tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarc...

Felodipine - felodipine tablet, film coated, extended release-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0672664-c12a-429a-a04f-62b75fcfb0ae

Nov 11th, 2020 - Felodipine tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have be...

Atenolol - atenolol tablet-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bdbf6779-8e9b-4ce1-a361-ede4914dd2f3

Nov 10th, 2020 - Atenolol is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in ...

Atenolol - atenolol tablet-direct rx
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b3d9f826-7ed7-1e3b-e053-2995a90ae731

Nov 10th, 2020 - Hypertension Atenolol tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benef...

Atenolol - atenolol tablet-direct rx
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b3c757de-1cbf-61f5-e053-2995a90accfc

Nov 9th, 2020 - Atenolol tablets USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have ...

see more →

News  25 results

Chronic, Preventive Care Fell as Telemedicine Soared During COVID
https://www.medscape.com/viewarticle/938615

Oct 4th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. As the COVID-19 pandemic drove down the number of primary care visits and altered the method — moving many to telehealth appointments instead of ...

Treatment Tips as COVID-19 Complicates CVD Management in Diabetes
https://www.staging.medscape.com/viewarticle/930994

May 21st, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape' Coronavirus Resource Center. A new article outlines the many ways in which the COVID-19 pandemic necessitates new considerations beyond traditional cardiovascular risk manageme...

Treatment Tips as COVID-19 Complicates CVD Management in Diabetes
https://www.medscape.com/viewarticle/930994

May 21st, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape' Coronavirus Resource Center. A new article outlines the many ways in which the COVID-19 pandemic necessitates new considerations beyond traditional cardiovascular risk manageme...

Cardiovascular risk management supported for type 2 diabetes
https://www.mdedge.com/neurology/article/172877/mixed-topics/cardiovascular-risk-management-supported-type-2-diabetes

Aug 17th, 2018 - Two studies published in the New England Journal of Medicine support managing cardiovascular risk in patients with type 2 diabetes. Also today, spontaneous intracranial hypotension is a triple misnomer, prolonged antimalarial therapy is linked to.

Studies support cardiovascular risk management in T2DM
https://www.mdedge.com/familymedicine/article/172698/diabetes/studies-support-cardiovascular-risk-management-t2dm/page/0/1
Clinical Endocrinology News;

Aug 15th, 2018 - The second study, which included 271,174 patients with T2DM from the Swedish National Diabetes Register and 1,355,870 controls, examined five risk factors: elevated glycated hemoglobin level, elevated low-density lipoprotein cholesterol level, alb.

see more →